CAV1 and pulmonary hypertension: Thus, development of therapeutic approaches involving endothelium-specific delivery of Cav-1 mimicking peptides or gene therapy restoring Cav-1 expression in endothelium of patients with pulmonary hypertension could be of clinical significance.